O	O	O	0	11	Salicylates	Salicylate	B-NP	NNS	O	2	SUB	O
O	O	O	12	19	inhibit	inhibit	B-VP	VBP	O	0	ROOT	O
O	O	O	20	38	lipopolysaccharide	lipopolysaccharide	B-NP	NN	O	7	NMOD	O
O	O	O	38	39	-	-	B-NP	HYPH	O	7	NMOD	O
O	O	O	39	46	induced	induce	I-NP	VBN	O	7	NMOD	O
O	O	O	47	62	transcriptional	transcriptional	I-NP	JJ	O	7	NMOD	O
O	O	O	63	73	activation	activation	I-NP	NN	O	2	OBJ	O
O	O	O	74	76	of	of	B-PP	IN	O	7	NMOD	O
O	O	O	77	80	the	the	B-NP	DT	O	12	NMOD	O
T17	B-Entity	B-Entity	81	87	tissue	tissue	I-NP	NN	B-DNA	12	NMOD	B-DNA
T17	I-Entity	I-Entity	88	94	factor	factor	I-NP	NN	I-DNA	12	NMOD	I-DNA
T17	I-Entity	I-Entity	95	99	gene	gene	I-NP	NN	I-DNA	8	PMOD	I-DNA
O	O	O	100	102	in	in	B-PP	IN	O	7	NMOD	O
O	O	O	103	108	human	human	B-NP	JJ	B-cell_type	16	NMOD	B-cell_type
O	O	O	109	118	monocytic	monocytic	I-NP	JJ	I-cell_type	16	NMOD	I-cell_type
O	O	O	119	124	cells	cell	I-NP	NNS	I-cell_type	13	PMOD	I-cell_type
O	O	O	124	125	.	.	O	.	O	2	P	O

O	O	O	127	134	Binding	Binding	B-NP	NN	O	0	ROOT	O
O	O	O	135	137	of	of	B-PP	IN	O	1	NMOD	O
O	O	O	138	144	plasma	plasma	B-NP	NN	B-protein	5	NMOD	B-protein
T1	B-Protein	B-Protein	145	151	Factor	Factor	I-NP	NN	I-protein	5	NMOD	I-protein
T1	I-Protein	I-Protein	152	155	VII	VII	I-NP	NN	I-protein	2	PMOD	I-protein
T1	I-Protein	I-Protein	155	156	/	/	O	SYM	O	5	NMOD	O
T1	I-Protein	I-Protein	156	160	VIIa	VIIa	B-NP	NN	B-protein	16	SUB	B-protein
O	O	O	161	163	to	to	B-PP	TO	O	7	NMOD	O
O	O	O	164	167	the	the	B-NP	DT	O	15	NMOD	O
T2	B-Protein	B-Protein	168	174	tissue	tissue	I-NP	NN	B-protein	15	NMOD	B-protein
T2	I-Protein	I-Protein	175	181	factor	factor	I-NP	NN	I-protein	15	NMOD	I-protein
T2	I-Protein	I-Protein	182	183	(	(	O	(	I-protein	15	NMOD	I-protein
T2	I-Protein	I-Protein	183	185	TF	TF	B-NP	NN	I-protein	15	NMOD	I-protein
T2	I-Protein	I-Protein	185	186	)	)	O	)	I-protein	15	NMOD	I-protein
T2	I-Protein	I-Protein	187	195	receptor	receptor	B-NP	NN	I-protein	8	PMOD	I-protein
O	O	O	196	205	initiates	initiate	B-VP	VBZ	O	6	SBAR	O
O	O	O	206	209	the	the	B-NP	DT	O	20	NMOD	O
O	O	O	210	221	coagulation	coagulation	I-NP	NN	B-protein	20	NMOD	B-protein
O	O	O	222	230	protease	protease	I-NP	NN	I-protein	20	NMOD	I-protein
O	O	O	231	239	cascades	cascade	I-NP	NNS	O	16	OBJ	O
O	O	O	239	240	.	.	O	.	O	1	P	O

T3	B-Protein	B-Protein	241	243	TF	TF	B-NP	NN	B-protein	2	NMOD	B-protein
O	O	O	244	254	expression	expression	I-NP	NN	O	6	SUB	O
O	O	O	255	257	by	by	B-PP	IN	O	2	NMOD	O
O	O	O	258	269	circulating	circulate	B-VP	VBG	B-cell_type	5	NMOD	B-cell_type
O	O	O	270	279	monocytes	monocyte	B-NP	NNS	I-cell_type	3	PMOD	I-cell_type
O	O	O	280	282	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	283	293	associated	associate	I-VP	VBN	O	6	VC	O
O	O	O	294	298	with	with	B-PP	IN	O	7	VMOD	O
O	O	O	299	309	thrombotic	thrombotic	B-NP	JJ	O	12	NMOD	O
O	O	O	310	313	and	and	I-NP	CC	O	12	NMOD	O
O	O	O	314	326	inflammatory	inflammatory	I-NP	JJ	O	12	NMOD	O
O	O	O	327	340	complications	complication	I-NP	NNS	O	8	PMOD	O
O	O	O	341	343	in	in	B-PP	IN	O	12	NMOD	O
O	O	O	344	345	a	a	B-NP	DT	O	15	NMOD	O
O	O	O	346	353	variety	variety	I-NP	NN	O	13	PMOD	O
O	O	O	354	356	of	of	B-PP	IN	O	15	NMOD	O
O	O	O	357	365	diseases	disease	B-NP	NNS	O	16	PMOD	O
O	O	O	365	366	.	.	O	.	O	6	P	O

O	O	O	367	382	Transcriptional	Transcriptional	B-NP	JJ	O	2	NMOD	O
O	O	O	383	393	activation	activation	I-NP	NN	O	18	SUB	O
O	O	O	394	396	of	of	B-PP	IN	O	2	NMOD	O
O	O	O	397	400	the	the	B-NP	DT	O	7	NMOD	O
O	O	O	401	406	human	human	I-NP	JJ	B-DNA	7	NMOD	B-DNA
T4	B-Protein	B-Protein	407	409	TF	TF	I-NP	NN	I-DNA	7	NMOD	I-DNA
O	O	O	410	414	gene	gene	I-NP	NN	I-DNA	3	PMOD	I-DNA
O	O	O	415	417	in	in	B-PP	IN	O	2	NMOD	O
O	O	O	418	427	monocytic	monocytic	B-NP	JJ	B-cell_type	10	NMOD	B-cell_type
O	O	O	428	433	cells	cell	I-NP	NNS	I-cell_type	8	PMOD	I-cell_type
O	O	O	434	441	exposed	expose	B-VP	VBN	O	10	NMOD	O
O	O	O	442	444	to	to	B-PP	TO	O	11	VMOD	O
O	O	O	445	454	bacterial	bacterial	B-NP	JJ	O	12	PMOD	O
O	O	O	455	473	lipopolysaccharide	lipopolysaccharide	I-NP	NN	O	13	NMOD	O
O	O	O	474	475	(	(	O	(	O	17	DEP	O
O	O	O	475	478	LPS	LPS	B-NP	NN	O	17	DEP	O
O	O	O	478	479	)	)	O	)	O	14	NMOD	O
O	O	O	480	482	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	483	491	mediated	mediate	I-VP	VBN	O	18	VC	O
O	O	O	492	494	by	by	B-PP	IN	O	19	VMOD	O
O	O	O	495	502	binding	binding	B-NP	NN	O	20	PMOD	O
O	O	O	503	505	of	of	B-PP	IN	O	21	NMOD	O
T5	B-Protein	B-Protein	506	507	c	c	B-NP	NN	B-protein	25	NMOD	B-protein
T5	I-Protein	I-Protein	507	508	-	-	O	HYPH	I-protein	25	P	I-protein
T5	I-Protein	I-Protein	508	511	Rel	Rel	B-NP	NN	I-protein	28	NMOD	I-protein
O	O	O	511	512	/	/	B-VP	SYM	O	28	P	O
T6	B-Protein	B-Protein	512	515	p65	p65	B-NP	NN	B-protein	28	NMOD	B-protein
T18	B-Entity	B-Entity	516	528	heterodimers	heterodimer	I-NP	NNS	I-protein	22	PMOD	I-protein
O	O	O	529	531	to	to	B-PP	TO	O	21	NMOD	O
O	O	O	532	533	a	a	B-NP	DT	O	33	NMOD	O
T19	B-Entity	B-Entity	534	539	kappa	kappa	I-NP	NN	B-DNA	33	NMOD	B-DNA
T19	I-Entity	I-Entity	540	541	B	B	I-NP	NN	I-DNA	33	NMOD	I-DNA
T19	I-Entity	I-Entity	542	546	site	site	I-NP	NN	I-DNA	29	PMOD	I-DNA
O	O	O	547	549	in	in	B-PP	IN	O	33	NMOD	O
O	O	O	550	553	the	the	B-NP	DT	O	37	NMOD	O
T7	B-Protein	B-Protein	554	556	TF	TF	I-NP	NN	B-DNA	37	NMOD	B-DNA
T20	B-Entity	B-Entity	557	565	promoter	promoter	I-NP	NN	I-DNA	34	PMOD	I-DNA
O	O	O	565	566	.	.	O	.	O	18	P	O

O	O	O	567	571	Here	Here	B-ADVP	RB	O	4	VMOD	O
O	O	O	571	572	,	,	O	,	O	4	P	O
O	O	O	573	575	we	we	B-NP	PRP	O	4	SUB	O
O	O	O	576	582	report	report	B-VP	VBP	O	0	ROOT	O
O	O	O	583	587	that	that	B-SBAR	IN	O	4	VMOD	O
O	O	O	588	589	a	a	B-NP	DT	O	7	NMOD	O
O	O	O	590	596	family	family	I-NP	NN	O	19	SUB	O
O	O	O	597	599	of	of	B-PP	IN	O	7	NMOD	O
O	O	O	600	604	anti	anti	B-NP	AFX	O	12	NMOD	O
O	O	O	604	605	-	-	I-NP	HYPH	O	12	P	O
O	O	O	605	617	inflammatory	inflammatory	I-NP	JJ	O	12	NMOD	O
O	O	O	618	624	agents	agent	I-NP	NNS	O	8	PMOD	O
O	O	O	624	625	,	,	O	,	O	7	P	O
O	O	O	626	631	known	know	B-VP	VBN	O	7	NMOD	O
O	O	O	632	634	as	as	B-PP	IN	O	14	VMOD	O
O	O	O	635	638	the	the	B-NP	DT	O	17	NMOD	O
O	O	O	639	650	salicylates	salicylate	I-NP	NNS	O	15	PMOD	O
O	O	O	650	651	,	,	O	,	O	7	P	O
O	O	O	652	661	inhibited	inhibit	B-VP	VBD	O	5	SBAR	O
O	O	O	662	665	LPS	LPS	B-NP	NN	O	21	NMOD	O
O	O	O	666	675	induction	induction	I-NP	NN	O	19	OBJ	O
O	O	O	676	678	of	of	B-PP	IN	O	21	NMOD	O
T8	B-Protein	B-Protein	679	681	TF	TF	B-NP	NN	B-protein	24	NMOD	B-protein
O	O	O	682	690	activity	activity	I-NP	NN	O	28	NMOD	O
O	O	O	691	694	and	and	I-NP	CC	O	28	NMOD	O
T9	B-Protein	B-Protein	695	697	TF	TF	I-NP	NN	B-DNA	27	NMOD	B-DNA
O	O	O	698	702	gene	gene	I-NP	NN	I-DNA	28	NMOD	I-DNA
O	O	O	703	716	transcription	transcription	I-NP	NN	O	22	PMOD	O
O	O	O	717	719	in	in	B-PP	IN	O	28	NMOD	O
O	O	O	720	725	human	human	B-NP	JJ	B-cell_type	31	NMOD	B-cell_type
O	O	O	726	735	monocytes	monocyte	I-NP	NNS	I-cell_type	37	NMOD	I-cell_type
O	O	O	736	739	and	and	O	CC	O	37	NMOD	O
O	O	O	740	749	monocytic	monocytic	B-NP	JJ	B-cell_line	34	NMOD	B-cell_line
O	O	O	750	753	THP	THP	I-NP	NN	I-cell_line	37	NMOD	I-cell_line
O	O	O	753	754	-	-	B-NP	HYPH	I-cell_line	37	NMOD	I-cell_line
O	O	O	754	755	1	1	I-NP	CD	I-cell_line	37	NMOD	I-cell_line
O	O	O	756	761	cells	cell	I-NP	NNS	I-cell_line	29	PMOD	I-cell_line
O	O	O	762	764	at	at	B-PP	IN	O	19	VMOD	O
O	O	O	765	775	clinically	clinically	B-NP	RB	O	40	AMOD	O
O	O	O	776	784	relevant	relevant	I-NP	JJ	O	41	NMOD	O
O	O	O	785	790	doses	dose	I-NP	NNS	O	38	PMOD	O
O	O	O	790	791	.	.	O	.	O	4	P	O

O	O	O	792	803	Furthermore	Furthermore	B-ADVP	RB	O	5	VMOD	O
O	O	O	803	804	,	,	O	,	O	5	P	O
O	O	O	805	811	sodium	sodium	B-NP	NN	O	4	NMOD	O
O	O	O	812	822	salicylate	salicylate	I-NP	NN	O	5	SUB	O
O	O	O	823	830	blocked	block	B-VP	VBD	O	0	ROOT	O
O	O	O	831	834	the	the	B-NP	DT	O	11	NMOD	O
O	O	O	835	838	LPS	LPS	I-NP	NN	O	11	NMOD	O
O	O	O	838	839	-	-	O	HYPH	O	7	P	O
O	O	O	839	846	induced	induce	B-NP	VBN	O	11	NMOD	O
O	O	O	847	858	proteolytic	proteolytic	I-NP	JJ	O	11	NMOD	O
O	O	O	859	870	degradation	degradation	I-NP	NN	O	5	OBJ	O
O	O	O	871	873	of	of	B-PP	IN	O	11	NMOD	O
T10	B-Protein	B-Protein	874	875	I	I	B-NP	NN	B-protein	16	NMOD	B-protein
T10	I-Protein	I-Protein	876	881	kappa	kappa	I-NP	NN	I-protein	16	NMOD	I-protein
T10	I-Protein	I-Protein	882	883	B	B	I-NP	NN	I-protein	16	NMOD	I-protein
T10	I-Protein	I-Protein	884	889	alpha	alpha	I-NP	NN	I-protein	12	PMOD	I-protein
O	O	O	889	890	,	,	O	,	O	5	P	O
O	O	O	891	896	which	which	B-NP	WDT	O	5	VMOD	O
O	O	O	897	906	prevented	prevent	B-VP	VBD	O	18	SBAR	O
O	O	O	907	910	the	the	B-NP	DT	O	22	NMOD	O
O	O	O	911	918	nuclear	nuclear	I-NP	JJ	O	22	NMOD	O
O	O	O	919	932	translocation	translocation	I-NP	NN	O	19	OBJ	O
O	O	O	933	935	of	of	B-PP	IN	O	22	NMOD	O
T11	B-Protein	B-Protein	936	937	c	c	B-NP	NN	B-protein	26	NMOD	B-protein
T11	I-Protein	I-Protein	937	938	-	-	O	HYPH	I-protein	26	P	I-protein
T11	I-Protein	I-Protein	938	941	Rel	Rel	B-NP	NN	I-protein	29	NMOD	I-protein
O	O	O	941	942	/	/	B-VP	SYM	O	29	P	O
T12	B-Protein	B-Protein	942	945	p65	p65	B-NP	NN	B-protein	29	NMOD	B-protein
T21	B-Entity	B-Entity	946	958	heterodimers	heterodimer	I-NP	NNS	I-protein	23	PMOD	I-protein
O	O	O	958	959	.	.	O	.	O	5	P	O

O	O	O	960	962	In	In	B-PP	IN	O	16	VMOD	O
O	O	O	963	971	contrast	contrast	B-NP	NN	O	1	PMOD	O
O	O	O	971	972	,	,	O	,	O	16	P	O
O	O	O	973	976	two	two	B-NP	CD	O	10	NMOD	O
O	O	O	977	982	other	other	I-NP	JJ	O	10	NMOD	O
O	O	O	983	995	nonsteroidal	nonsteroidal	I-NP	JJ	O	10	NMOD	O
O	O	O	996	1000	anti	anti	I-NP	AFX	O	10	NMOD	O
O	O	O	1000	1001	-	-	I-NP	HYPH	O	10	NMOD	O
O	O	O	1001	1013	inflammatory	inflammatory	I-NP	JJ	O	10	NMOD	O
O	O	O	1014	1019	drugs	drug	I-NP	NNS	O	14	NMOD	O
O	O	O	1019	1020	,	,	O	,	O	14	P	O
O	O	O	1021	1030	ibuprofen	ibuprofen	B-NP	NN	O	14	NMOD	O
O	O	O	1031	1034	and	and	I-NP	CC	O	14	NMOD	O
O	O	O	1035	1047	indomethacin	indomethacin	I-NP	NN	O	16	SUB	O
O	O	O	1047	1048	,	,	O	,	O	14	P	O
O	O	O	1049	1052	did	do	B-VP	VBD	O	0	ROOT	O
O	O	O	1053	1056	not	not	I-VP	RB	O	16	VMOD	O
O	O	O	1057	1064	inhibit	inhibit	I-VP	VB	O	16	VC	O
O	O	O	1065	1068	LPS	LPS	B-NP	NN	O	20	NMOD	O
O	O	O	1069	1078	induction	induction	I-NP	NN	O	18	OBJ	O
O	O	O	1079	1081	of	of	B-PP	IN	O	20	NMOD	O
O	O	O	1082	1085	the	the	B-NP	DT	O	24	NMOD	O
T13	B-Protein	B-Protein	1086	1088	TF	TF	I-NP	NN	B-DNA	24	NMOD	B-DNA
O	O	O	1089	1093	gene	gene	I-NP	NN	I-DNA	21	PMOD	I-DNA
O	O	O	1093	1094	.	.	O	.	O	16	P	O

O	O	O	1095	1100	These	These	B-NP	DT	O	2	NMOD	O
O	O	O	1101	1108	results	result	I-NP	NNS	O	3	SUB	O
O	O	O	1109	1118	indicated	indicate	B-VP	VBD	O	0	ROOT	O
O	O	O	1119	1123	that	that	B-SBAR	IN	O	3	VMOD	O
O	O	O	1124	1135	salicylates	salicylate	B-NP	NNS	O	6	SUB	O
O	O	O	1136	1145	inhibited	inhibit	B-VP	VBD	O	4	SBAR	O
O	O	O	1146	1149	LPS	LPS	B-NP	NN	O	8	NMOD	O
O	O	O	1150	1159	induction	induction	I-NP	NN	O	6	OBJ	O
O	O	O	1160	1162	of	of	B-PP	IN	O	8	NMOD	O
T14	B-Protein	B-Protein	1163	1165	TF	TF	B-NP	NN	B-DNA	11	NMOD	B-DNA
O	O	O	1166	1170	gene	gene	I-NP	NN	I-DNA	12	NMOD	I-DNA
O	O	O	1171	1184	transcription	transcription	I-NP	NN	O	9	PMOD	O
O	O	O	1185	1187	in	in	B-PP	IN	O	8	NMOD	O
O	O	O	1188	1197	monocytic	monocytic	B-NP	JJ	B-cell_type	15	NMOD	B-cell_type
O	O	O	1198	1203	cells	cell	I-NP	NNS	I-cell_type	13	PMOD	I-cell_type
O	O	O	1204	1206	by	by	B-PP	IN	O	6	VMOD	O
O	O	O	1207	1217	preventing	prevent	B-VP	VBG	O	16	PMOD	O
O	O	O	1218	1225	nuclear	nuclear	B-NP	JJ	O	19	NMOD	O
O	O	O	1226	1239	translocation	translocation	I-NP	NN	O	17	OBJ	O
O	O	O	1240	1242	of	of	B-PP	IN	O	19	NMOD	O
T15	B-Protein	B-Protein	1243	1244	c	c	B-NP	NN	B-protein	23	NMOD	B-protein
T15	I-Protein	I-Protein	1244	1245	-	-	O	HYPH	I-protein	23	P	I-protein
T15	I-Protein	I-Protein	1245	1248	Rel	Rel	B-NP	NN	I-protein	26	NMOD	I-protein
O	O	O	1248	1249	/	/	B-VP	SYM	O	26	P	O
T16	B-Protein	B-Protein	1249	1252	p65	p65	B-NP	NN	B-protein	26	NMOD	B-protein
T22	B-Entity	B-Entity	1253	1265	heterodimers	heterodimer	I-NP	NNS	I-protein	20	PMOD	I-protein
O	O	O	1265	1266	.	.	O	.	O	3	P	O

O	O	O	1267	1270	The	The	B-NP	DT	O	3	NMOD	O
O	O	O	1271	1279	clinical	clinical	I-NP	JJ	O	3	NMOD	O
O	O	O	1280	1288	benefits	benefit	I-NP	NNS	O	19	SUB	O
O	O	O	1289	1291	of	of	B-PP	IN	O	3	NMOD	O
O	O	O	1292	1303	salicylates	salicylate	B-NP	NNS	O	4	PMOD	O
O	O	O	1304	1306	in	in	B-PP	IN	O	3	NMOD	O
O	O	O	1307	1310	the	the	B-NP	DT	O	8	NMOD	O
O	O	O	1311	1320	treatment	treatment	I-NP	NN	O	6	PMOD	O
O	O	O	1321	1323	of	of	B-PP	IN	O	8	NMOD	O
O	O	O	1324	1331	several	several	B-NP	JJ	O	11	NMOD	O
O	O	O	1332	1340	diseases	disease	I-NP	NNS	O	9	PMOD	O
O	O	O	1340	1341	,	,	O	,	O	11	P	O
O	O	O	1342	1351	including	include	B-PP	VBG	O	11	NMOD	O
O	O	O	1352	1367	atherosclerosis	atherosclerosis	B-NP	NN	O	17	NMOD	O
O	O	O	1368	1371	and	and	O	CC	O	17	NMOD	O
O	O	O	1372	1382	rheumatoid	rheumatoid	B-NP	JJ	O	17	NMOD	O
O	O	O	1383	1392	arthritis	arthritis	I-NP	NN	O	13	PMOD	O
O	O	O	1392	1393	,	,	O	,	O	3	P	O
O	O	O	1394	1397	may	may	B-VP	MD	O	0	ROOT	O
O	O	O	1398	1400	be	be	I-VP	VB	O	19	VC	O
O	O	O	1401	1408	related	relate	I-VP	VBN	O	20	PRD	O
O	O	O	1409	1411	to	to	B-PP	TO	O	21	AMOD	O
O	O	O	1412	1417	their	their	B-NP	PRP$	O	24	NMOD	O
O	O	O	1418	1425	ability	ability	I-NP	NN	O	22	PMOD	O
O	O	O	1426	1428	to	to	B-VP	TO	O	26	VMOD	O
O	O	O	1429	1435	reduce	reduce	I-VP	VB	O	24	NMOD	O
O	O	O	1436	1444	monocyte	monocyte	B-NP	NN	O	29	NMOD	O
O	O	O	1445	1449	gene	gene	I-NP	NN	O	29	NMOD	O
O	O	O	1450	1460	expression	expression	I-NP	NN	O	26	OBJ	O
O	O	O	1460	1461	.	.	O	.	O	19	P	O
